Results 11 to 20 of about 22,235 (205)
Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects. [PDF]
ABSTRACT Mucormycosis, an aggressive fungal infection caused by members of the order Mucorales, progresses rapidly and is associated with high mortality, particularly in immunocompromised hosts such as patients with uncontrolled diabetes, transplant recipients or those with COVID‐19‐associated immunosuppression. Early diagnosis remains challenging with
Qu Y, Xiao Y, Liu L, Qu J.
europepmc +2 more sources
Upper Jaw Mucormycosis in an Immunocompetent Patient: A Clinical Report. [PDF]
Mucormycosis is a rare but severe opportunistic infection, whose incidence has substantially increased since the coronavirus disease 2019 (COVID‐19) pandemic. It predominantly affects immunocompromised patients, individuals with diabetes, and those receiving corticosteroids.
Thepenier C +5 more
europepmc +2 more sources
Fatal Renal Mucormycosis Following Pediatric Deceased Donor Kidney Transplantation in a High-Risk Recipient: A Case Report. [PDF]
ABSTRACT Background Mucormycosis is a rare but devastating opportunistic fungal infection in immunocompromised hosts with particularly high morbidity and mortality in solid organ transplant recipients. Pediatric cases are exceedingly rare, and outcomes are often fatal.
Levy CS +8 more
europepmc +2 more sources
Prosthetic Management of a Maxillofacial Defect Post-Mucormycosis: A Case Report. [PDF]
Introduction Mucormycosis is a rare, aggressive fungal infection primarily affecting immunocompromised individuals. It can lead to significant tissue necrosis, including maxillary destruction. This case report explores the prosthetic rehabilitation of a patient with a severe maxillary defect caused by rhinocerebral mucormycosis, focusing on the ...
Kazemi F +4 more
europepmc +2 more sources
AbstractThree cases of mucormycosis are presented; two with unusual aspects: One with previously unreported involvement of the mandible, and one presenting as a cavernous sinus thrombosis.Review of the literature reveals a limited number of survivors.
L, Eisenberg, T, Wood, R, Boles
openaire +2 more sources
Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis. [PDF]
PM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Bai Y +5 more
europepmc +2 more sources
COVID19 associated mucormycosis: A review
Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the mucormycetes group of molds. Immunocompromised states such as diabetes, chronic steroid use,
Priyadharsini R Palanisamy +1 more
doaj +1 more source
A short review on black fungal mucormycosis accompanied by Post-SARS-CoV-2
Many people who have recovered from coronavirus disease 2019 (COVID-19) have recently been diagnosed with black fungus – or mucormycosis – disease. Rhino-orbital mucormycosis is becoming more common in people with COVID-19, particularly in India.
Abhishek Lachyan +3 more
doaj +1 more source
Invasive fungal infections secondary to traumatic injury [PDF]
Invasive fungal infection (IFI) is a rare but serious complication of traumatic injury. The purpose of this article is to review the epidemiology, natural history, mycology, risk factors, diagnosis, treatment, and outcomes associated with post-traumatic ...
Bochicchio, Grant +5 more
core +3 more sources
Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. It is frequent in poorly controlled diabetic patients and individuals with immunosuppression. It is usually acquired by direct inoculation through trauma.
Castrejón Pérez, Ana Daniela +4 more
openaire +6 more sources

